Compare BEDU & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BEDU | YI |
|---|---|---|
| Founded | 1994 | 2010 |
| Country | United Kingdom | China |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Retail-Drug Stores and Proprietary Stores |
| Sector | Real Estate | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 65.0M | 38.1M |
| IPO Year | 2017 | N/A |
| Metric | BEDU | YI |
|---|---|---|
| Price | $2.19 | $3.75 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 4.7K | ★ 11.5K |
| Earning Date | 01-23-2026 | 12-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $224,321,752.00 | ★ $1,979,883,442.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.35 | $3.19 |
| 52 Week High | $2.28 | $11.35 |
| Indicator | BEDU | YI |
|---|---|---|
| Relative Strength Index (RSI) | 57.57 | 40.75 |
| Support Level | $2.14 | $3.60 |
| Resistance Level | $2.22 | $3.88 |
| Average True Range (ATR) | 0.03 | 0.19 |
| MACD | -0.00 | 0.04 |
| Stochastic Oscillator | 43.75 | 69.51 |
Bright Scholar Education Holdings Ltd operates as an education service provider. It is engaged in the provision of education services, including complementary education services, operation services for domestic schools, and education programs and services including independent schools and colleges in United Kingdom and the United States. It nearly eight overseas school located in the United Kingdom and the United States. It has three reportable segments, including Overseas Schools, Complementary Education Services, and K-12 Operation Services. Key revenue is generated from Overseas Schools. From a geographical perspective: Key revenue is generated from China following UK, U.S., Canada and Singapore.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.